Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) FCF Margin (2023 - 2025)

Mangoceuticals (MGRX) has disclosed FCF Margin for 3 consecutive years, with 1142.18% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 6892.0% to 1142.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1282.89% through Dec 2025, down 49315.0% year-over-year, with the annual reading at 1282.89% for FY2025, 49315.0% down from the prior year.
  • FCF Margin hit 1142.18% in Q4 2025 for Mangoceuticals, up from 1473.38% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 462.94% in Q1 2024 to a low of 2081.11% in Q1 2025.
  • Historically, FCF Margin has averaged 1106.1% across 3 years, with a median of 1019.96% in 2024.
  • Biggest five-year swings in FCF Margin: surged 133589bps in 2024 and later crashed -161817bps in 2025.
  • Year by year, FCF Margin stood at 694.73% in 2023, then crashed by -54bps to 1073.26% in 2024, then decreased by -6bps to 1142.18% in 2025.
  • Business Quant data shows FCF Margin for MGRX at 1142.18% in Q4 2025, 1473.38% in Q3 2025, and 747.4% in Q2 2025.